According to GlobalData’s medical device pipeline database, 27 Needle Free Injections devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 12 are in active development, while the remaining 20 are in an inactive stage of development. There are seven products in the early stages of development, and the remaining five are in the late stages of development.
Needle-free Injections are the devices that do not use a needle to administer medication. They propel a small jet of liquid or powder at high speed through a microscopic orifice causing it to penetrate the skin for subcutaneous, intra-dermal, or intramuscular administration. Disposable needle free syringes are not tracked in this category. Needle free injection comprises of three parts – durable injector, disposable vial adapter and needle free syringes. Disposable components like vial adapters and syringes that come only with the first purchase of needle free syringe system is tracked and disposable components for subsequent use of the injectors are not tracked. Pre filled needle-free injections are not covered under this category. One unit refers to one needle free injection.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Needle Free Injections pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Needle Free Injections devices. Overall, most of these Needle Free Injections pipeline devices are being developed by private entities.
Key players involved in the active development of Needle Free Injections include Crossject, Inovio Pharmaceuticals, Medical International Technologies (Mit Canada), PharmaJet, Teva Pharmaceutical Industries, Enable Injections, Eternity Healthcare, aVaxziPen and Boston Scientific.
For a complete picture of the developmental pipeline for Needle Free Injections devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
